top of page
340B Drug Pricing Program: Analysis Reveals $40 Billion in Profits in 2019
Client:
Year:
Analysis of 2019 Profits and Sales in 340B at the Therapeutic Area Based on FOIA Request
bottom of page
Client:
Year:
Analysis of 2019 Profits and Sales in 340B at the Therapeutic Area Based on FOIA Request